DAWN (Day One Biopharmaceuticals) FCF Yield %: -4.84 (As of Jun. 24, 2026)


DAWN Day One Biopharmaceuticals Inc DAWN
12 GF Score
Price $21.53
! 5 Warning Signs
View Full Analysis

What is Day One Biopharmaceuticals FCF Yield %?

Day One Biopharmaceuticals DAWN 12 FCF Yield % is -4.84 as of Jun. 24, 2026. GuruFocus rates DAWN with a GF Score™ of 12/100. The stock has 5 warning signs investors should review. Among 1,417 Biotechnology companies, Day One Biopharmaceuticals ranks better than 62.88% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Day One Biopharmaceuticals's Trailing 12-Month Free Cash Flow is $-107.6 Mil, and Market Cap is $2,224.8 Mil. Therefore, Day One Biopharmaceuticals's FCF Yield % for today is -4.84%.

The historical rank and industry rank for Day One Biopharmaceuticals's FCF Yield % or its related term are showing as below:

DAWN' s FCF Yield % Range Over the Past 10 Years
Min: -16.58   Med: -9.58   Max: -4.82
Current: -4.84

During the past 7 years, the highest FCF Yield % of Day One Biopharmaceuticals was -4.82%. The lowest was -16.58%. And the median was -9.58%.

DAWN's FCF Yield % is ranked better than
62.88% of 1417 companies
in the Biotechnology industry
Industry Median: -9.7 vs DAWN: -4.84

Day One Biopharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2025 was -26.34%.

Day One Biopharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Day One Biopharmaceuticals FCF Yield % Related Terms

Day One Biopharmaceuticals FCF Yield % Historical Data

* Premium members only.

The historical data trend for Day One Biopharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Day One Biopharmaceuticals FCF Yield % Chart

Day One Biopharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial -5.42 -6.95 -11.78 -11.89 -11.21

Day One Biopharmaceuticals Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.37 -31.26 -14.90 -3.21 -5.90

DAWN vs TYRA, DFTX, MLYS: FCF Yield % Comparison

For the Biotechnology subindustry, Day One Biopharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Day One Biopharmaceuticals FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Day One Biopharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Day One Biopharmaceuticals's FCF Yield % falls into.


DAWN
12GF Score
Day One Biopharmaceuticals Inc DAWN
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Day One Biopharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Day One Biopharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-107.577 / 959.80156
=-11.21%

Day One Biopharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-14.149 * 4 / 959.80156
=-5.90%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -4.84 mean?
Day One Biopharmaceuticals (DAWN) has a FCF Yield % of -4.84 as of Jun. 24, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Day One Biopharmaceuticals and its competitors. According to the industry distribution chart, Day One Biopharmaceuticals ranks #526 out of 1417 companies in the Biotechnology industry, placing it in the top 37.1%.
Is Day One Biopharmaceuticals' FCF Yield % too high?
Day One Biopharmaceuticals' current FCF Yield % is -4.84. Based on the distribution chart, Day One Biopharmaceuticals ranks #526 out of 1417 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Day One Biopharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Day One Biopharmaceuticals' FCF Yield % compare to TYRA and DFTX?
According to the Biotechnology industry distribution chart, Day One Biopharmaceuticals ranks #526 out of 1417 companies for FCF Yield %. This puts Day One Biopharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Day One Biopharmaceuticals and its competitors. Day One Biopharmaceuticals's current FCF Yield % is -4.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Day One Biopharmaceuticals stock overvalued right now?
Day One Biopharmaceuticals (DAWN) has a current FCF Yield % of -4.84. The current FCF Yield % is -4.84. Day One Biopharmaceuticals' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Day One Biopharmaceuticals (DAWN), the current FCF Yield % is -4.84 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Day One Biopharmaceuticals Business Description

Address 1800 Sierra Point Parkway, Suite 200, Brisbane, CA, USA, 94005
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
12GF Score

Get the complete analysis for DAWN

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.53
Price